Group One Trading
XENE icon

Group One Trading’s Xenon Pharmaceuticals XENE Stock Holding History

Group One Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,556
Closed -$149K – 9306
2025
Q3 		$143K Sell
3,556
-1,097
-24% -$38.6K ﹤0.01% 5001
2025
Q2 		$146K Buy
+4,653
New +$152K ﹤0.01% 4646
2024
Q4 		– Sell
-104
Closed -$4.3K – 8056
2024
Q3 		$4.09K Buy
104
+100
+2,500% +$4.03K ﹤0.01% 5954
2024
Q2 		$156 Buy
+4
New +$160 ﹤0.01% 6529
2023
Q4 		– Sell
-8,005
Closed -$283K – 8299
2023
Q3 		$273K Buy
+8,005
New +$299K ﹤0.01% 3524
2023
Q1 		– Sell
-6,552
Closed -$242K – 8053
2022
Q4 		$258K Sell
6,552
-5,021
-43% -$183K ﹤0.01% 3638
2022
Q3 		$418K Buy
11,573
+2,813
+32% +$101K ﹤0.01% 3408
2022
Q2 		$266K Buy
8,760
+4,153
+90% +$126K ﹤0.01% 4023
2022
Q1 		$141K Buy
+4,607
New +$138K ﹤0.01% 5155
2021
Q3 		– Sell
-890
Closed -$15.5K – 8880
2021
Q2 		$17K Buy
+890
New +$16.4K ﹤0.01% 7295

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Group One Trading's XENE Position: Q4 2025 in Review

Group One Trading sold out of Xenon Pharmaceuticals (XENE) in Q4 2025, closing a stake of 3,556 shares — an estimated $149K sold.

Group One Trading first reported a position in XENE in Q2 2021 and held it in 10 quarters. The position peaked at $418K in Q3 2022. 246 funds tracked by Wall St. Rank hold XENE as of Q4 2025.

  • Group One Trading reported no remaining Xenon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 3,556 Xenon Pharmaceuticals shares in Q4 2025, an estimated $149K.
  • Group One Trading first reported a position in Xenon Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • Group One Trading's Xenon Pharmaceuticals position peaked at $418K in Q3 2022.
  • 246 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.